Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Invested Capital (2016 - 2026)

Ekso Bionics Holdings has reported Invested Capital over the past 14 years, most recently at $11.0 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 13.16% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.0 million, a 13.16% decrease, with the full-year FY2025 number at $11.0 million, down 13.16% from a year prior.
  • Invested Capital reached $11.0 million in Q4 2025 per EKSO's latest filing, down from $11.6 million in the prior quarter.
  • The five-year high for Invested Capital was $41.0 million in Q1 2021, with the low at $10.9 million in Q2 2025.
  • The 5-year median for Invested Capital is $16.5 million (2023), against an average of $22.2 million.
  • Peak YoY movement for Invested Capital: surged 143300.0% in 2021, then tumbled 50.45% in 2023.
  • Tracing EKSO's Invested Capital over 5 years: stood at $37.2 million in 2021, then tumbled by 31.64% to $25.4 million in 2022, then tumbled by 50.45% to $12.6 million in 2023, then grew by 0.8% to $12.7 million in 2024, then fell by 13.16% to $11.0 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $11.0 million, $11.6 million, and $10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.